Bookmark and Share
LMP1 (geneid:3783750) - Gene BioActivity Data
Also known as: HHV4_LMP-1.
BioActivity Outcomes:
Active(3079)
 
 
Inactive(345472)
 
 
Inconclusive(509)
 
 
BioAssay Types:
Screening(345298)
 
 
 
 
Confirmatory(3762)
 
 
 
 
BioActivity Types:
AC50(3723)
 
 
 
 
Substance Types:
Chemical(349060)
 
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 5    Data Row: 349060   Total Pages: 17453   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID24783710]
[CID16188230]
AC50_uM 0.011Viability counterscreen of potential LMP-1 inhibitors in HEK293 cell background Measured in Cell-Based System Using Plate Reader - 2122-02_Inhibitor_Dose_CherryPick_Activity [AID504861, Type: confirmatory] [gi:23893668]
View
2
[SID49681549]
[CID165528]
AC50_uM 0.016Viability counterscreen of potential LMP-1 inhibitors in HEK293 cell background Measured in Cell-Based System Using Plate Reader - 2122-02_Inhibitor_Dose_CherryPick_Activity [AID504861, Type: confirmatory] [gi:23893668]
View
3
[SID99359775]
[CID3034634]
AC50_uM 0.037Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504882, Type: confirmatory] [gi:23893668]
View
4
[SID92764240]
[CID3005038]
AC50_uM 0.055Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504882, Type: confirmatory] [gi:23893668]
View
5
[SID99360910]
[CID3000575]
AC50_uM 0.068Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504882, Type: confirmatory] [gi:23893668]
View
6
[SID14745672]
[CID5371064]
AC50_uM 0.13Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504882, Type: confirmatory] [gi:23893668]
View
7
[SID92764242]
[CID3005734]
AC50_uM 0.138Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504882, Type: confirmatory] [gi:23893668]
View
8
[SID24827393]
[CID16240103]
AC50_uM 0.147TES1 - eGFP vs TES2 -dsRED Pathway Differentiation Measured in Cell-Based System Using Imaging - 2122-04_Inhibitor_Dose_CherryPick_Activity [AID588398, Type: confirmatory] [gi:23893668]
View
9
[SID92764431]
[CID392789]
AC50_uM 0.154Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504882, Type: confirmatory] [gi:23893668]
View
10
[SID131451069]
[CID54654640]
AbsAC35_uM 0.161TNFalpha- eGFP -dsRED Canonical Pathway Differentiation Measured in Cell-Based System Using Flow Cytometry - 2122-08_Inhibitor_Dose_DryPowder_Activity [AID652043, Type: confirmatory] [gi:23893668]
View
11
[SID92764431]
[CID392789]
AC50_uM 0.252Viability counterscreen of potential LMP-1 inhibitors in HEK293 cell background Measured in Cell-Based System Using Plate Reader - 2122-02_Inhibitor_Dose_CherryPick_Activity [AID504861, Type: confirmatory] [gi:23893668]
View
12
[SID92764241]
[CID3005039]
AC50_uM 0.269Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504882, Type: confirmatory] [gi:23893668]
View
13
[SID26671096]
[CID6891857]
AC50_uM 0.288TES1 - eGFP vs TES2 -dsRED Pathway Differentiation Measured in Cell-Based System Using Imaging - 2122-04_Inhibitor_Dose_CherryPick_Activity [AID588398, Type: confirmatory] [gi:23893668]
View
14
[SID136920236]
AbsAC35_uM 0.29TNFalpha- eGFP -dsRED Canonical Pathway Differentiation Measured in Cell-Based System Using Flow Cytometry - 2122-08_Inhibitor_Dose_DryPowder_Activity [AID652043, Type: confirmatory] [gi:23893668]
View
15
[SID17386515]
[CID570353]
AC50_uM 0.298Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504882, Type: confirmatory] [gi:23893668]
View
16
[SID92763443]
[CID3004977]
AC50_uM 0.354Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504882, Type: confirmatory] [gi:23893668]
View
17
[SID24827393]
[CID16240103]
AC50_uM 0.354Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504882, Type: confirmatory] [gi:23893668]
View
18
[SID92763866]
[CID3003955]
AC50_uM 0.362Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504882, Type: confirmatory] [gi:23893668]
View
19
[SID7977511]
[CID869474]
AC50_uM 0.371Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504882, Type: confirmatory] [gi:23893668]
View
20
[SID7974678]
[CID2854508]
AC50_uM 0.379Lymphoblastoid Cells (LCL) Cytotoxicity Secondary Assay Measured in Cell-Based System Using Plate Reader - 2122-03_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504882, Type: confirmatory] [gi:23893668]
View